These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 34809634)

  • 1. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer.
    Wang M; Xue W; Yuan H; Wang Z; Yu L
    Int J Nanomedicine; 2024; 19():2823-2849. PubMed ID: 38525013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of cancer-associated fibroblasts by nanodelivery system to enhance efficacy of tumor therapy.
    Ai W; Liu T; Lv C; Feng X; Wang Q
    Nanomedicine (Lond); 2023 Jun; 18(15):1025-1039. PubMed ID: 37584613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Strategies for the Treatment of Hepatocellular Carcinoma by Modulating the Tumor Microenvironment via Nano-Delivery Systems: A Review.
    Huang Y; Wang T; Yang J; Wu X; Fan W; Chen J
    Int J Nanomedicine; 2022; 17():2335-2352. PubMed ID: 35619893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking Down Barriers in Drug Delivery by Stromal Remodeling Approaches in Pancreatic Cancer.
    Zhou Y; Ma Y; Sheng J; Ma Y; Ding J; Zhou W
    Mol Pharm; 2024 Aug; 21(8):3764-3776. PubMed ID: 39049481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration.
    Guo J; Zeng H; Chen Y
    Mol Pharm; 2020 Apr; 17(4):1028-1048. PubMed ID: 32150417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles designed to regulate tumor microenvironment for cancer therapy.
    Li M; Zhang F; Su Y; Zhou J; Wang W
    Life Sci; 2018 May; 201():37-44. PubMed ID: 29577880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy.
    Truffi M; Mazzucchelli S; Bonizzi A; Sorrentino L; Allevi R; Vanna R; Morasso C; Corsi F
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boosting antitumor efficacy of nanoparticles by modulating tumor mechanical microenvironment.
    Zhang X; Zhang X; Yong T; Gan L; Yang X
    EBioMedicine; 2024 Jul; 105():105200. PubMed ID: 38876044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonic-hedgehog pathway inhibition normalizes desmoplastic tumor microenvironment to improve chemo- and nanotherapy.
    Mpekris F; Papageorgis P; Polydorou C; Voutouri C; Kalli M; Pirentis AP; Stylianopoulos T
    J Control Release; 2017 Sep; 261():105-112. PubMed ID: 28662901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
    Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
    Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments.
    Xue X; Wang X; Pang M; Yu L; Qian J; Li X; Tian M; Lu C; Xiao C; Liu Y
    J Nanobiotechnology; 2024 Apr; 22(1):196. PubMed ID: 38644492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the tumor microenvironment for pancreatic ductal adenocarcinoma therapy.
    Zhang YF; Jiang SH; Hu LP; Huang PQ; Wang X; Li J; Zhang XL; Nie HZ; Zhang ZG
    Chin Clin Oncol; 2019 Apr; 8(2):18. PubMed ID: 31070038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.
    Li X; Ma Q; Xu Q; Duan W; Lei J; Wu E
    Curr Pharm Des; 2012; 18(17):2404-15. PubMed ID: 22372501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-Associated Fibroblasts and Extracellular Matrix: Therapeutical Strategies for Modulating the Cholangiocarcinoma Microenvironment.
    Minini M; Fouassier L
    Curr Oncol; 2023 Apr; 30(4):4185-4196. PubMed ID: 37185432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
    Yang S; Gao H
    Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reflections on depletion of tumor stroma in pancreatic cancer.
    Wang WQ; Liu L; Xu JZ; Yu XJ
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):267-272. PubMed ID: 30738097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
    Urbanova M; Cihova M; Buocikova V; Slopovsky J; Dubovan P; Pindak D; Tomas M; García-Bermejo L; Rodríguez-Garrote M; Earl J; Kohl Y; Kataki A; Dusinska M; Sainz B; Smolkova B; Gabelova A
    Biomed Pharmacother; 2023 Sep; 165():115179. PubMed ID: 37481927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.